Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soshi Nishibu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Biological & Pharmaceutical Bulletin|December 24, 2025
DNA-Damaging Agents Induce PD-L1 Expression through the Src-STAT1-IRF1 PathwayYuri Suzuki, Soshi Nishibu, Akihiro Nohara, et al.
Biological & Pharmaceutical Bulletin|November 20, 2024
HDAC Inhibitors Induce HLA Class I Molecules through the SOX10-IRF1 Axis in Clear Cell Sarcoma CellsMinh Thi Nguyen, Ryota Kikuchi, Soshi Nishibu, et al.
Cancer Research|November 3, 2021
SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 AxisSatoru Yokoyama, Atsushi Takahashi, Ryota Kikuchi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Biological & Pharmaceutical Bulletin|December 24, 2025
DNA-Damaging Agents Induce PD-L1 Expression through the Src-STAT1-IRF1 PathwayYuri Suzuki, Soshi Nishibu, Akihiro Nohara, et al.
Biological & Pharmaceutical Bulletin|November 20, 2024
HDAC Inhibitors Induce HLA Class I Molecules through the SOX10-IRF1 Axis in Clear Cell Sarcoma CellsMinh Thi Nguyen, Ryota Kikuchi, Soshi Nishibu, et al.
Cancer Research|November 3, 2021
SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 AxisSatoru Yokoyama, Atsushi Takahashi, Ryota Kikuchi, et al.
Pageof 1